AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

FORTERRA PLC

Business and Financial Review Jan 22, 2020

5334_rns_2020-01-22_2862b24f-9aa9-470b-bb8e-e6c1442c0874.html

Business and Financial Review

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5128A

Forterra plc

22 January 2020

22 January 2020

Forterra plc

Trading update

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update for the year ended 31 December 2019.

The Group demonstrated its resilience during the final quarter in the face of continued political and economic uncertainty in the UK and we anticipate underlying 2019 full year profit before tax to be in line with the Board's expectations.

Looking ahead, the Board expects the challenging market conditions experienced in the second half of 2019 to gradually improve but anticipates that the Group's performance in the first half of 2020 will be below that achieved in the first half of 2019. The Board continues to see a market underpinned by strong fundamentals.

The construction of our new plant at Desford is progressing to plan and we expect the structure of the building to be completed in the spring ready for the fit out and installation of the manufacturing equipment.

Annual results for the financial year ended 31 December 2019 will be announced on 10 March 2020.

Enquiries

Forterra plc: +44 (0) 1604 707 600
Stephen Harrison (CEO)
Ben Guyatt (CFO)
FTI Consulting: +44 (0) 20 3727 1340
Richard Mountain
Nick Hasell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TSTDGGDBCDDDGGB

Talk to a Data Expert

Have a question? We'll get back to you promptly.